Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease.
Irie M, Sohda T, Anan A, Fukunaga A, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S. Irie M, et al. Among authors: fukunaga a. Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):13-18. doi: 10.5005/jp-journals-10018-1159. Epub 2016 Jul 9. Euroasian J Hepatogastroenterol. 2016. PMID: 29201718 Free PMC article.
Oxidative stress may also contribute to clinical progression from simple fatty liver (FL) to NASH. A therapy for insulin resistance and antioxidant has been applied to treat NASH, yet these treatments are not fully established. ...DISCUSSION: The present pilot study demons …
Oxidative stress may also contribute to clinical progression from simple fatty liver (FL) to NASH. A therapy for insulin resistance a …
Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinoma.
Morihara D, Iwata K, Hanano T, Kunimoto H, Kuno S, Fukunaga A, Yotsumoto K, Takata K, Tanaka T, Sakurai K, Iwashita H, Ueda S, Hirano G, Yokoyama K, Nakane H, Nishizawa S, Yoshikane M, Anan A, Takeyama Y, Kakumitsu S, Kitamura Y, Sakamoto M, Irie M, Shakado S, Sohda T, Watanabe H, Sakisaka S. Morihara D, et al. Among authors: fukunaga a. Hepatol Res. 2012 Jul;42(7):658-67. doi: 10.1111/j.1872-034X.2012.00969.x. Epub 2012 Mar 2. Hepatol Res. 2012. PMID: 22380706
Levels of the oxidative stress marker γ-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease.
Irie M, Sohda T, Iwata K, Kunimoto H, Fukunaga A, Kuno S, Yotsumoto K, Sakurai K, Iwashita H, Hirano G, Ueda SI, Yokoyama K, Morihara D, Nishizawa S, Anan A, Takeyama Y, Sakamoto M, Shakado S, Sakisaka S. Irie M, et al. Among authors: fukunaga a. J Int Med Res. 2012;40(3):924-33. doi: 10.1177/147323001204000311. J Int Med Res. 2012. PMID: 22906265 Free article.
Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate.
Morihara D, Watanabe H, Takata K, Iwashita H, Tsuchiya N, Kunimoto H, Kuno S, Fukunaga A, Yotsumoto K, Tanaka T, Sakurai K, Hirano G, Yokoyama K, Nishizawa S, Yoshikane M, Anan A, Takeyama Y, Kitamura Y, Iwata K, Irie M, Shakado S, Sohda T, Sakisaka S. Morihara D, et al. Among authors: fukunaga a. Eur J Gastroenterol Hepatol. 2015 Jan;27(1):55-64. doi: 10.1097/MEG.0000000000000208. Eur J Gastroenterol Hepatol. 2015. PMID: 25370853
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis.
Takeyama Y, Tsuchiya N, Kunimoto H, Fukunaga A, Sakurai K, Hirano G, Yokoyama K, Morihara D, Anan A, Irie M, Shakado S, Sohda T, Sakisaka S. Takeyama Y, et al. Among authors: fukunaga a. Hepatol Res. 2015 Oct;45(10):E108-14. doi: 10.1111/hepr.12470. Epub 2015 Mar 2. Hepatol Res. 2015. PMID: 25560223
Pilot Study of Hepatic Arterial Infusion Chemotherapy with Interferon-beta and 5-fluorouracil: A New Chemotherapy for Patients with Advanced Hepatocellular Carcinoma.
Shakado S, Iwata K, Tsuchiya N, Kunimoto H, Yotsumoto K, Fukunaga A, Kuno S, Tanaka T, Sakurai K, Iwashita H, Hirano G, Yokoyama K, Morihara D, Nishizawa S, Takeyama Y, Irie M, Sohda T, Kora S, Yoshimitsu K, Sakisaka S. Shakado S, et al. Among authors: fukunaga a. Hepatogastroenterology. 2014 May;61(131):557-62. Hepatogastroenterology. 2014. PMID: 26176035 Clinical Trial.
Eosinophilic gastroenteritis in a patient with chronic hepatitis C who received treatment with pegylated interferon.
Hirano G, Fukunaga A, Sohda T, Kunimoto H, Yotsumoto K, Sakurai K, Iwashita H, Ueda S, Yokoyama K, Morihara D, Tomioka Y, Anan A, Yamaguchi M, Takeyama Y, Eguchi K, Sakamoto M, Irie M, Iwata K, Shakado S, Aoyagi K, Sakisaka S. Hirano G, et al. Among authors: fukunaga a. Clin J Gastroenterol. 2012 Apr;5(2):127-30. doi: 10.1007/s12328-012-0289-2. Epub 2012 Feb 24. Clin J Gastroenterol. 2012. PMID: 26182155
A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin.
Shakado S, Akehi Y, Yotsumoto K, Fukunaga A, Kuno S, Tanaka T, Sakurai K, Iwashita H, Ueda S, Hirano G, Yokoyama K, Morihara D, Nishizawa S, Sakamoto M, Anan A, Takeyama Y, Irie M, Iwata K, Sohda T, Sakisaka S. Shakado S, et al. Among authors: fukunaga a. Clin J Gastroenterol. 2011 Aug;4(4):255-261. doi: 10.1007/s12328-011-0228-7. Epub 2011 Jun 10. Clin J Gastroenterol. 2011. PMID: 26189530
387 results